Home › Funds › FPA Queens Road Value Fund
Fund family: Investment Managers Series Trust III · Filed by Investment Managers Series Trust III (CIK 924727) · SEC series S000080695
Ticker: QRVLX (C000243218)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 357 with, 25 against, 0 abstentions (not counted as with management). Shareholder proposals: 1 FOR, 24 AGAINST, 0 abstained, by the filing’s own vote-source field.
No item-level comparison with other Investment Managers Series Trust III funds is possible: no ballot item of this fund was voted by at least three other funds of the family with a clear majority.
The same votes as “with management” above, by the sector of the company voted on. 100.0% of this fund’s 382 such votes could be given a sector.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Finance | 101 | 8 | 7.9% |
| Industrials | 84 | 0 | 0.0% |
| Health Care | 64 | 6 | 9.4% |
| Technology | 49 | 3 | 6.1% |
| Consumer Discretionary | 44 | 5 | 11.4% |
| Consumer Staples | 27 | 2 | 7.4% |
| Telecommunications | 13 | 1 | 7.7% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 288 | 0 |
| Say-on-Pay | 29 | 0 |
| Audit-related | 26 | 0 |
| Corporate Governance | 10 | 9 |
| Capital Structure | 8 | 0 |
| Compensation | 6 | 0 |
| Environment or Climate | 6 | 6 |
| Other Social Issues | 6 | 6 |
| Human Rights or Human Capital/workforce | 3 | 3 |
| Extraordinary Transactions | 1 | 0 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| American Express Company | May 5, 2026 | $4M | 17 | 2 |
| Ameriprise Financial, Inc. | April 29, 2026 | $3M | 10 | 0 |
| JPMorgan Chase & Co. | May 19, 2026 | $3M | 17 | 4 |
| General Dynamics Corporation | May 6, 2026 | $3M | 14 | 0 |
| Centene Corporation | May 12, 2026 | $2M | 12 | 1 |
| The Bank of New York Mellon Corporation | April 14, 2026 | $2M | 13 | 0 |
| Pfizer Inc. | April 23, 2026 | $2M | 16 | 1 |
| Oracle Corporation | November 18, 2025 | $2M | 15 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| May 5, 2026 | American Express Company | Shareholder proposal requesting a report on coverage of transgender healthcare treatments for minors. Shareholder proposal | Against | For |
| May 5, 2026 | American Express Company | Shareholder proposal regarding political bias risk oversight. Shareholder proposal | Against | For |
| May 19, 2026 | JPMorgan Chase & Co. | Report on congruence of security, resiliency, and climate initiatives Shareholder proposal | Against | For |
| May 19, 2026 | JPMorgan Chase & Co. | Independent board chairman Shareholder proposal | Against | For |
| May 12, 2026 | Centene Corporation | STOCKHOLDER PROPOSAL REGARDING AN INDEPENDENT BOARD CHAIRMAN. Shareholder proposal | Against | For |
| April 23, 2026 | Pfizer Inc. | Adopt an Independent Chair Policy Shareholder proposal | Against | For |
| May 13, 2026 | Elevance Health, Inc. | Shareholder Proposal Requesting an Independent Study on the Impact of Prohibiting Corporate Contributions to Partisan 527 Tax-Exempt Political Groups. Shareholder proposal | Against | For |
| May 26, 2026 | Merck & Co., Inc. | Shareholder proposal regarding a report on DEI risks in federal contracting. Shareholder proposal | Against | For |
| May 26, 2026 | Merck & Co., Inc. | Shareholder proposal regarding a report on healthcare coverage gaps. Shareholder proposal | Against | For |
| December 16, 2025 | Cisco Systems, Inc. | Stockholder Proposal - Approval to request the Board to conduct an evaluation and issue a report assessing how Cisco's Inclusion programs provide positive financial value to shareholders. Shareholder proposal | Against | For |
| May 13, 2026 | Intel Corporation | Stockholder proposal requesting a report on risk of China exposure. Shareholder proposal | Against | For |
| May 13, 2026 | Intel Corporation | Stockholder proposal requesting a report on Intel's human rights due diligence process. Shareholder proposal | Against | For |
384 ballot items at 28 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, FPA Queens Road Value Fund (QRVLX) voted at 28 shareholder meetings of 27 companies, on 384 ballot items in all. Where management made a recommendation, the fund followed it on 93.5% of the items and voted against it 25 times. Its most frequent area of disagreement was corporate governance (9 of its votes against management). It voted on 25 shareholder proposals.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026. The interactive database shows the same votes company by company, with every other fund that voted.